YOKOHAMA SAKAE KYOSAI HOSPITAL

Zimmer Biomet Receives World's First PMDA Approval for Iodine-Treated Hip Replacement System

- Zimmer Biomet received Japan PMDA approval for the iTaperloc Complete and iG7 Hip System, marking the world's first approved orthopedic implants with iodine technology designed to inhibit bacterial adhesion and prevent biofilm formation. - The innovative system addresses periprosthetic joint infection (PJI), which occurs in 1-2% of primary total joint arthroplasty procedures and carries mortality rates approaching those of breast cancer at 11%. - The iodine technology applies a controlled-release iodine layer through advanced anodization and electrophoresis during manufacturing, utilizing iodine's biocompatible properties without causing antibiotic resistance. - This approval strengthens Zimmer Biomet's infection management portfolio and represents a significant advancement in orthopedic implant design for improving patient safety in joint replacement surgeries.